Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|May 18, 2026
Preclinical and clinical evaluation of futibatinib in combination with binimetinib in patients with advanced cancerJordi Rodon, Bert O'Neil, Christopher Lim, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2017
The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancerGrant R Williams, Allison M Deal, Shlomit Strulov Shachar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 TrialJean-Sebastien Frenel, Christophe Le Tourneau, Bert O'Neil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186Cameron J Herting, Matthew R Farren, Yan Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
BMC Genomics|May 14, 2024
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, et al.
JCO Precision Oncology|March 23, 2022
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated CancersMohamed E Salem, Sherif M El-Refai, Wei Sha, et al.
The Oncologist|June 5, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancerHanna K Sanoff, Allison M Deal, Jai Patel, et al.
Pageof 5